Fast axonal transport
movement of membranous organelles at rates of 200-400 mm/day along axonal microtubules in both the anterograde (carries synaptic vesicle precursors, large dense core vesicles, elements of the smooth endoplasmic reticulum, protein particles carrying RNAs) and retrograde (delivers components for degradation through fusion with lysosomes and signals that regulate gene expression) directions.
Synaptic vesicle life cycle:
Canonical pathway for neurotransmitter release and recycling
Kiss and run
kiss and stay
Neuropeptide, monoamine vs small neurotransmitter
Neuropeptide is synthesized in the cell body and carried via anterograde transport to the release site maturing in the transported vesicle. Neuropeptides are modulatory and no recycling of the neuropeptides, precursors or dense-core vesicles. Can be released from any point in the neuron, requires higher stimulation as is further from Ca efflux site.
Neuropeptide synthesis
Synthesized in the cell body as pre-propeptides, if no pre signaling tail attached, packed into dense-core vesicles and transported via anterograde transport. Final form of neuropeptide is achieved after maturation in the vesicles during transport until it reaches the release site.
Transporter types:
Efficacy
ability to initiate change.
ionotropic receptors
Ionotropic receptors are composed of multiple subunits each consisting of 4 transmembrane domains. Mediates fast synaptic transmission via substrate binding which elicits ion channel opening and leads to polarization or hyperpolarization of the membrane.
Guanylyl cyclase receptors
have a single transmembrane domain. Agonist binding leads to activation of guanylyl cyclase catalytic region. Decrease in cGMP leads to closing of cGMP gated cation channels (visual, olfactory systems).
Tyrosine kinase receptors
consist of single transmembrane domain. Agonist binding causes receptor dimerization leading to stimulation of the catalytic region – autophosphorylation. Signaling cascade.
G protein coupled receptors
G protein coupled receptors consist of 7 transmembrane domains and activates guanosine triphosphate binding proteins which leads to second messenger cascade (regulation of K and Ca channel conductance, adenylyl cyclase activity, PI-PLC activation and production of IP3.
Acetylcholine in the neuromuscular junction
a. ACh is released from the presynaptic neuron
b. ACh binds to ligand-gated Na channel
c. Depolarization of the end-plate membrane
d. Opening of Na voltage gated channels
e. Action potential at the sarcolemma of muscle fiber
f. Contraction
a. Myelinated efferent preganglionic neurons of the sympathetic and parasympathetic NS synapse on the postganglionic neurons activating nicotinic ACh receptors.
b. Signal travels through the unmyelinated postganglionic neuron which synapses onto the end organ, parasympathetic neuron on muscarinic ACh receptors and the sympathetic neuron releases norepinephrine on adrenoceptors.
ACh in the CNS
a. The interneurons in the striatum
b. Basal forebrain cholinergic complex – ascending arousal system (projects to olfactory bulb, cerebral cortex, hippocampus, habenula, amygdala)
c. Pontomesencephalotegmental cholinergic complex – locomotion, sleep, attention, posture (projects to thalamus, tectum, habenula, vta, cerebellum, vestibular and cranial nerve nuclei.
Acetylcholine synthesis
Choline + Acetyl CoA → Ach + CoA (by acetyltransferase (ChAT))
ACh degradation
ACh + H2O → Choline + Acetate (by acetylcholinesterase (AChE))
ACh cycle
nACh
nACh receptors are composed of pentameric subunits (at least 2 α) crossing the membrane 4 times. α5 subunit influences Ca permeability. At least 2 ACh are required to bind for activation (α β for neurons). In neurons usually present in a ratio of 3α:2β.
mACh receptors
mACh receptors composed of one unit consisting of 7 subunits crossing the membrane. Can be both post and presynaptic, in the neuromuscular junction are expressed on the presynaptic neurons as inhibitory autoreceptors. M1, M3, M5 stimulation of phospholipase C (postsynaptic)(cerebral cortex, striatum, thalamus, brainstem) – elevates Ca, M2, M4 – inhibition of AC (post and presynaptic) (cerebral cortex, striatum, hypothalamus) - affects channel activity.
Norepinephrine cell groups
(A1-7):
* The dorsal bundle (locus coeruleus) (A4-6)– projects to cerebral cortex, hippocampus, cerebellum, brainstem and spinal cord. Ascending arousal system, vigilance and responsiveness to unexpected stimuli.
* The lateral ventral tegmental fields (A5-7) – project to the spinal cord and hypothalamus. Belong to the reticular formation, modulating autonomic reflexes and pain sensation.
* Medullary group (A1-2) – project to hypothalamus, concerned with autonomic functions.
Dopamine cell groups
(A8-17):
* Nigrostriatal pathway (A8,9) – from substantia nigra projects towards striatum for movement initiation, compulsive behaviour, habit formation.
* Mesocorticolimbic pathway (A10) – from VTA to frontal and temporal cortex, the limbic structures of the basal forebrain. Play a role in reward, motivation, emotion and memory.
* Minor cell groups:
o A11 and A13 – in the hypothalamus project to the autonomic areas of lower brainstem and spinal cord – regulation of the sympathetic preganglionic neurons.
o A12,14,15 – components of the endocrine system. Prolactin and gonadotrophin regulation.
o A17 – retina
o A16 – olfactory bulb
Synthesis of catecholamines:
Tyrosine -> (TH) L-DOPA -> (DDC) dopamine.
Dopamine -> (DBH) Norepinephrine -> (PNMT) Epinephrine
Tyrosine hydroxylase, dopa-decarboxylase, dopamine β-hydroxylase, PNMT